Literature DB >> 8636280

Immunoradiometric assay for follistatin: serum immunoreactive follistatin levels in normal adults and pregnant women.

M Wakatsuki1, Y Shintani, M Abe, Z H Liu, K Shitsukawa, S Saito.   

Abstract

A sensitive and specific immunoradiometric assay for follistatin was developed using antifollistatin mouse monoclonal and rabbit polyclonal antibodies. The sensitivity of the assay was 0.5 micrograms/L, and cross-reactivities with recombinant human activin A and bovine inhibin were less than 0.1%. The intra- and interassay coefficients of variation were less than 10%, and the recovery rate was about 90% in human serum. The addition of activin A to the same sample resulted in a minimal influence on follistatin recovery, indicating that this assay system can measure the total level of activin-bound and unbound follistatin. Gel filtration analysis of human serum showed that the majority of immunoreactivity was eluted in a larger molecular size position than that of free follistatin, suggesting that the large part of follistatin is bound to other proteins, presumably activins, in serum. Using this assay, immunoreactive follistatin levels in various biological fluids and human sera were examined. The dose-response curves of porcine follicular and amniotic fluids were parallel to the standard curve, and porcine follicular fluid contained extremely high follistatin immunoreactivity (5.6 mg/L). The serum follistatin level in normal human volunteers was 13.3 +/- 4.7 micrograms/L (mean +/- SD; n = 60), with a tendency to increase gradually with age. On the other hand, the serum follistatin level was remarkably elevated in pregnant women (62.7 +/- 35.3 micrograms/L; n = 57), with a positive correlation with weeks of pregnancy. These data indicated that circulating immunoreactive follistatin is detectable in human serum, and the levels vary with physiological conditions such as aging and pregnancy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636280     DOI: 10.1210/jcem.81.2.8636280

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Differential effects of aging on activin A and its binding protein, follistatin, across the menopause transition.

Authors:  Nancy E Reame; Jane L Lukacs; Pamela Olton; Rudi Ansbacher; Vasantha Padmanabhan
Journal:  Fertil Steril       Date:  2007-04-16       Impact factor: 7.329

2.  Interleukin-1 beta enhances and interferon-gamma suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts.

Authors:  M Abe; Y Shintani; Y Eto; K Harada; Y Fujinaka; M Kosaka; T Matsumoto
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 3.  Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease.

Authors:  Louise R Rodino-Klapac; Amanda M Haidet; Janaiah Kota; Chalonda Handy; Brian K Kaspar; Jerry R Mendell
Journal:  Muscle Nerve       Date:  2009-03       Impact factor: 3.217

4.  Follistatin is a novel biomarker for lung adenocarcinoma in humans.

Authors:  Fangfang Chen; Ping Ren; Ye Feng; Haiyan Liu; Yang Sun; Zhonghui Liu; Jingyan Ge; Xueling Cui
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

5.  Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure.

Authors:  Qun Wei; Haiyan Liu; Miao Liu; Chunyan Yang; Jie Yang; Zhonghui Liu; Ping Yang
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

6.  Activin A and follistatin as biomarkers for ectopic pregnancy and missed abortion.

Authors:  Alexandros Daponte; Efthimios Deligeoroglou; Antonios Garas; Spyros Pournaras; Christos Hadjichristodoulou; Ioannis E Messinis
Journal:  Dis Markers       Date:  2013-10-07       Impact factor: 3.434

7.  Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism.

Authors:  Fen-Yu Tseng; Yen-Ting Chen; Yu-Chao Chi; Pei-Lung Chen; Wei-Shiung Yang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

Review 8.  Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Toshifumi Sugatani
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

9.  Association of serum follistatin levels with histological types and progression of tumor in human lung cancer.

Authors:  Pengyu Zhang; Yingxin Ruan; Jun Xiao; Fangfang Chen; Xuejun Zhang
Journal:  Cancer Cell Int       Date:  2018-10-20       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.